A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer
Imugene Limited
Imugene Limited
Azienda Sanitaria-Universitaria Integrata di Udine
China-Japan Friendship Hospital
Multitude Therapeutics Inc.
Fudan University
Fudan University
The University Clinic of Pulmonary and Allergic Diseases Golnik
Guangzhou Institute of Respiratory Disease
Shanghai Pulmonary Hospital, Shanghai, China
Fujian Cancer Hospital
Hunan Cancer Hospital
Aristotle University Of Thessaloniki
Konkuk University Medical Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lund University Hospital
National Taiwan University Hospital
Sohag University
Central Hospital, Nancy, France
Peking University People's Hospital
RenJi Hospital
University College, London
Peking University People's Hospital
Samsung Medical Center
SpeciCare
Shanghai Pulmonary Hospital, Shanghai, China
Henan University of Traditional Chinese Medicine
Henan Cancer Hospital
Sun Yat-sen University
Geneplus-Beijing Co. Ltd.
Fujian Cancer Hospital
The University of Hong Kong
Peking University Cancer Hospital & Institute
First People's Hospital of Hangzhou
Third Military Medical University
Shanghai Chest Hospital
First People's Hospital of Hangzhou
University Hospital, Montpellier
Hospices Civils de Lyon
Anhui Provincial Hospital
First People's Hospital of Hangzhou
Southwest Hospital, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
People's Hospital of Guangxi Zhuang Autonomous Region
Hunan Province Tumor Hospital
Capital Medical University
Meir Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The First Affiliated Hospital of Guangzhou Medical University
National Cancer Institute (NCI)